Cancer lettersHumansCarcinomaHepatocellularLiver NeoplasmsQuinolines
Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib response.
Shi-Yu Zhang, De-Zhen Guo, Xin Zhang, Zhu-Jun Gu, Ling Aye, Jia-Yan Yan, Kai Zhu, Xiu-Tao Fu, Shuang-Tao Zhou, Da-Wei Jin, Guo-Huan Yang, Qi-Man Sun, Yi-Feng He, Kang Song, Xiao-Wu Huang
Published: 202610.1016/j.canlet.2025.218212
Abstract
Minimal residual disease (MRD) is proposed to drive early recurrence of hepatocellular carcinoma (HCC) after curative treatment, and patients with MRD may benefit from adjuvant treatment. We applied a customized targeted deep sequencing (TDS) to prof…
Preview only. Read the full abstract at the source